Form 4: MicroVision Director Robert Paul Carlile Reports Stock Transaction
SEC Form 4
Director Robert Paul Carlile reports acquisition of 11,439 shares of MicroVision common stock through vested restricted stock units.
Summary
- On May 17, 2024, Robert Paul Carlile, a director of MicroVision, Inc., acquired 11,439 shares of common stock.
- The acquisition was a result of the vesting of restricted stock units (RSUs).
- The RSUs converted into shares of common stock on a unit-for-share basis without any payment required.
- Following the transaction, Carlile directly owns 204,328 shares of MicroVision common stock.
- The RSUs were granted on May 17, 2023, and vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2024 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of a director's stock transaction.
Positives
- The vesting of RSUs indicates continued alignment of the director's interests with those of the shareholders.
Industry Context
This is a standard SEC Form 4 filing, reflecting a director's stock transaction. Such filings are common and provide transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director's ownership.
Key Dates
| Date | Description |
|---|---|
| 05/17/2023 | RSUs granted to Robert Paul Carlile |
| 05/17/2024 | Date of transaction: vesting of RSUs and acquisition of common stock |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.